| PharmaTutor

11 January 2010

Hip Fracture Risk Elevated With Pernicious Anemia: Study

January 8, 2010 — Patients with pernicious anemia have significantly higher risks for hip fracture, research shows.

Compared to age- and sex-matched controls, patients with pernicious anemia had a 73% greater risk of hip fracture (3.4 vs. 2.0 hip fractures/1000 person-years of follow-up). The elevated risk was even greater with newly diagnosed pernicious anemia (HR, 2.63).

11 January 2010

Thoracoabdominal Calcifications May Predict Cardiovascular Mortality

January 8, 2010 — Thoracoabdominal calcifications on radiography predict cardiovascular and total mortality, according to the results of an 18-year follow-up study reported online in the December 15, 2009, issue of Diabetes Care.

11 January 2010

Sopherion gets US FDA fast track status for Myocet in metastatic breast cancer

Sopherion Therapeutics, LLC, a bio-pharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced that it has received Fast Track Designation from the US Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet) for first-line therapy of HER2 positive metastatic breast cancer. Treatment with Myocet has already shown a reduced level of cardiotoxicity as compared to traditional doxorubicin.

11 January 2010

Career Opportunity in Business Development at Stride Acrolabs

Stride Arcolabs

Work as Head / Manager – BD (International Operations)

10 January 2010

RENOTICE: Entrance Exam for NIPER, JEE-2010

NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), 2010